Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples

[1]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[2]  X. Chen,et al.  Comparison of Nanostring nCounter® Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues , 2016, PloS one.

[3]  Hans Clevers,et al.  Single-cell messenger RNA sequencing reveals rare intestinal cell types , 2015, Nature.

[4]  R. Salazar,et al.  Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Salto‐Tellez,et al.  Re: test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data. , 2014, Journal of the National Cancer Institute.

[6]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[7]  P. Gibbs,et al.  Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  R. Coffey,et al.  Deciphering Genomic Alterations in Colorectal Cancer through Transcriptional Subtype-Based Network Analysis , 2013, PloS one.

[9]  Mingguang Shi,et al.  A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients , 2012, PloS one.

[10]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[11]  Paul C. Boutros,et al.  NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data , 2012, Bioinform..

[12]  Dimitris Anastassiou,et al.  Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo , 2011, BMC Cancer.

[13]  Sridhar Ramaswamy,et al.  Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Yeatman,et al.  Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer , 2011, Gut.

[15]  Maureen A. Smith,et al.  Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  L. Waldron,et al.  mRNA transcript quantification in archival samples using multiplexed, color-coded probes , 2011, BMC biotechnology.

[17]  Hans Clevers,et al.  The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. , 2011, Cell stem cell.

[18]  David B Jackson,et al.  EMT is the dominant program in human colon cancer , 2011, BMC Medical Genomics.

[19]  S. Paik,et al.  Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Yeatman,et al.  Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. , 2010, Gastroenterology.

[21]  J. Budczies,et al.  A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. , 2009, Gastroenterology.

[22]  S. Mukherjee,et al.  Adjuvant therapy for completely resected stage II colon cancer. , 2008, The Cochrane database of systematic reviews.

[23]  Elena A. Manilich,et al.  Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer. , 2008, Journal of Molecular Diagnostics.

[24]  P. Fortina,et al.  Digital mRNA profiling , 2008, Nature Biotechnology.

[25]  S. Rha,et al.  Whole genome analysis for liver metastasis gene signatures in colorectal cancer , 2007, International journal of cancer.

[26]  A. Labarga,et al.  A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients. , 2007, Oncology reports.

[27]  S. Dudoit,et al.  Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling , 2007, Oncogene.

[28]  N. Kasabov,et al.  Multiple Gene Expression Classifiers from Different Array Platforms Predict Poor Prognosis of Colorectal Cancer , 2007, Clinical Cancer Research.

[29]  S. Dudoit,et al.  Stage II colon cancer prognosis prediction by tumor gene expression profiling. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  I. Yang,et al.  Molecular staging for survival prediction of colorectal cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  David C. Atkins,et al.  Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[33]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[34]  X. Chen,et al.  Molecular and Cellular Pathobiology Nuclear Factor of Activated T-cell Activity Is Associated with Metastatic Capacity in Colon Cancer , 2014 .

[35]  Sabine Tejpar,et al.  Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data. , 2014, Journal of the National Cancer Institute.

[36]  Evaluating RNA Quality from FFPE Samples Guidelines for obtaining high-quality RNA sequencing results from degraded RNA with the TruSeq , 2014 .

[37]  L. V. van't Veer,et al.  Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  P. Nelson,et al.  Microarray bioinformatics. , 2011, Methods in molecular biology.

[39]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[40]  R. Simon,et al.  Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. , 2007, Cancer research.

[41]  B. Glimelius,et al.  A systematic overview of chemotherapy effects in colorectal cancer. , 2001, Acta oncologica.

[42]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[43]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[44]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.